BRIA
CONSUMER CYCLICALBrilliA Inc - Class A
Live · AMEX · May 8, Close
What's Moving BRIA Today?
No stock-specific AI insight has been generated for BRIA yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.74
Fundamentals
Trading
BRIA News
9 articles- BrilliA Reports Positive Operating Cash Flow and Cost Reduction for the Six Months Ended September 30, 2025Yahoo Finance·Mar 24, 2026
- BrilliA Expands into Japan’s Athleisure SectorYahoo Finance·Feb 23, 2026
- BrilliA Reports on NYSE Bell Ringing on August 25thYahoo Finance·Sep 9, 2025
- Wall Street Set to Open Higher Friday; Nonfarm Payrolls Fall Well Short of ForecastsYahoo Finance·Sep 5, 2025
- BrilliA Inc Declares Cash Dividend of $0.13 per Class A ShareYahoo Finance·Sep 3, 2025
- Marvell downgraded, Dollar Tree upgraded: Wall Street's top analyst callsYahoo Finance·Aug 29, 2025
- Diamond Equity Research Releases Update Note on Brillia, Inc. (NYSEAM: BRIA)Yahoo Finance·Jul 24, 2025
- BrilliA Inc Filed Its Form 20-F On July 22, 2025Yahoo Finance·Jul 24, 2025
- BrilliA Announces 15 Percent Revenue Growth, Earnings of $2.8 Million, for Year Ended March 31, 2025Yahoo Finance·Jul 22, 2025
All 9 articles loaded
Price Data
52-Week Range
$1.74
Fundamentals
Trading
About BrilliA Inc - Class A
BrilliA Inc. is a pioneering biotechnology firm focused on advancing skin health and regenerative medicine by developing innovative solutions for wound healing and enhancing patient quality of life. Leveraging cutting-edge proprietary technologies, BrilliA aims to address critical unmet medical needs in the healthcare sector. Committed to rigorous research and development, the company is strategically positioned to transform scientific breakthroughs into impactful therapeutic products, reinforcing its leadership in a dynamic and rapidly evolving market.